• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Celmatix Sues Research Partner 23andMe for $100M

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    FDA Cleared New Cochlear Osia 2 System

    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

    Lens-Free Microendoscope Generates High Quality Images
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Command Medical Products Inc.

    NN Life Sciences/Paragon Medical

    Halkey-Roberts Corporation

    Pulse Systems

    Lyons
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Marox Corporation

    MicroLumen Inc.

    Lyons

    S-Y-M Products Company

    Zeus
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Biochip Sensor Helps Diagnose Sepsis in Minutes

    When time matters in hospitals, an automated system can detect an early biomarker for the potentially life-threatening condition.

    Biochip Sensor Helps Diagnose Sepsis in Minutes
    An MIT-invented microfluidics device could help doctors diagnose sepsis, a leading cause of death in U.S. hospitals, by automatically detecting elevated levels of a sepsis biomarker in about 25 minutes, using less than a finger prick of blood. Image courtesy of Felice Frankel.
    Related CONTENT
    • Ingestible, Expanding Pill Monitors Stomach for up to a Month
    • Electrifying Healthcare: A Look at Electronics Manufacturing Services for Medtech
    • Neurostim Tech Leads the Charge at CES
    • Pill Can Deliver Insulin via Stomach Injection
    • ExThera Medical Elects Two New Board Members
    Rob Matheson, MIT News Office07.23.19
    A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
     
    Sepsis occurs when the body’s immune response to infection triggers an inflammation chain reaction throughout the body, causing high heart rate, high fever, shortness of breath, and other issues. If left unchecked, it can lead to septic shock, where blood pressure falls and organs shut down. To diagnose sepsis, doctors traditionally rely on various diagnostic tools, including vital signs, blood tests, and other imaging and lab tests.
     
    In recent years, researchers have found protein biomarkers in the blood that are early indicators of sepsis. One promising candidate is interleukin-6 (IL-6), a protein produced in response to inflammation. In sepsis patients, IL-6 levels can rise hours before other symptoms begin to show. But even at these elevated levels, the concentration of this protein in the blood is too low overall for traditional assay devices to detect it quickly.
     
    In a paper being presented this week at the Engineering in Medicine and Biology Conference, MIT researchers describe a microfluidics-based system that automatically detects clinically significant levels of IL-6 for sepsis diagnosis in about 25 minutes, using less than a finger prick of blood.

    In one microfluidic channel, microbeads laced with antibodies mix with a blood sample to capture the IL-6 biomarker. In another channel, only beads containing the biomarker attach to an electrode. Running voltage through the electrode produces an electrical signal for each biomarker-laced bead, which is then converted into the biomarker concentration level.
     
    “For an acute disease, such as sepsis, which progresses very rapidly and can be life-threatening, it’s helpful to have a system that rapidly measures these nonabundant biomarkers,” said first author Dan Wu, a PhD student in the Department of Mechanical Engineering. “You can also frequently monitor the disease as it progresses.”
     
    Joining Wu on the paper is Joel Voldman, a professor and associate head of the Department of Electrical Engineering and Computer Science, co-director of the Medical Electronic Device Realization Center, and a principal investigator in the Research Laboratory of Electronics and the Microsystems Technology Laboratories.
     
    Integrated, Automated Design
    Traditional assaid that detect protein biomarkers are bulky, expensive machines relegated to labs that require about a milliliter of blood and produce results in hours. In recent years, portable “point-of-care” systems have been developed that use microliters of blood to get similar results in about 30 minutes.
     
    But point-of-care systems can be very expensive since most use pricey optical components to detect the biomarkers. They also capture only a small number of proteins, many of which are among the more abundant ones in blood. Any efforts to decrease the price, shrink down components, or increase protein ranges negatively impacts their sensitivity.
     
    In their work, the researchers wanted to shrink components of the magnetic-bead-based assay, which is often used in labs, onto an automated microfluidics device that’s roughly several square centimeters. That required manipulating beads in micron-sized channels and fabricating a device in the Microsystems Technology Laboratory that automated the movement of fluids.
     
    The beads are coated with an antibody that attracts IL-6, as well as a catalyzing enzyme called horseradish peroxidase. The beads and blood sample are injected into the device, entering into an “analyte-capture zone,” which is basically a loop. Along the loop is a peristaltic pump—commonly used for controlling liquids—with valves automatically controlled by an external circuit. Opening and closing the valves in specific sequences circulates the blood and beads to mix together. After about 10 minutes, the IL-6 proteins have bound to the antibodies on the beads.
     
    Automatically reconfiguring the valves at that time forces the mixture into a smaller loop, called the “detection zone,” where they stay trapped. A tiny magnet collects the beads for a brief wash before releasing them around the loop. After about 10 minutes, many beads have stuck on an electrode coated with a separate antibody that attracts IL-6. At that time, a solution flows into the loop and washes the untethered beads, while the ones with IL-6 protein remain on the electrode.
     
    The solution carries a specific molecule that reacts to the horseradish enzyme to create a compound that responds to electricity. When a voltage is applied to the solution, each remaining bead creates a small current. A common chemistry technique called “amperometry” converts that current into a readable signal. The device counts the signals and calculates the concentration of IL-6.
     
    “On their end, doctors just load in a blood sample using a pipette. Then, they press a button and 25 minutes later they know the IL-6 concentration,” Wu said.
     
    The device uses about 5 microliters of blood, which is about a quarter the volume of blood drawn from a finger prick and a fraction of the 100 microliters required to detect protein biomarkers in lab-based assaid. The device captures IL-6 concentrations as low as 16 picograms per milliliter, which is below the concentrations that signal sepsis, meaning the device is sensitive enough to provide clinically relevant detection.
     
    A General Platform
    The current design has eight separate microfluidics channels to measure as many different biomarkers or blood samples in parallel. Different antibodies and enzymes can be used in separate channels to detect different biomarkers, or different antibodies can be used in the same channel to detect several biomarkers simultaneously.
     
    Next, the researchers plan to create a panel of important sepsis biomarkers for the device to capture, including interleukin-6, interleukin-8, C-reactive protein, and procalcitonin. But there’s really no limit to how many different biomarkers the device can measure, for any disease, Wu said. Notably, more than 200 protein biomarkers for various diseases and conditions have been approved by the U.S. Food and Drug Administration.
     
    “This is a very general platform,” Wu said. “If you want to increase the device’s physical footprint, you can scale up and design more channels to detect as many biomarkers as you want.”
     
    The work was funded by Analog Devices, Maxim Integrated, and the Novartis Institutes of Biomedical Research.
    Related Searches
    • blood
    • mit
    • first
    • it
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    TransEnterix Announces Japanese Regulatory Approval of the Senhance Surgical System TransEnterix Announces Japanese Regulatory Approval of the Senhance Surgical System
    From One Brain Scan, More Info for Medical AI From One Brain Scan, More Info for Medical AI
    4 Factors Leading to the Growth of IoT in Healthcare 4 Factors Leading to the Growth of IoT in Healthcare
    Using AI to Predict Breast Cancer and Personalize Care Using AI to Predict Breast Cancer and Personalize Care
    Lantos Technologies Launches the Only FDA-Cleared 3D Ear Scanning System Lantos Technologies Launches the Only FDA-Cleared 3D Ear Scanning System
    Developing Market Access Strategies Developing Market Access Strategies
    Consumer-Minded Design Consumer-Minded Design
    Imaging System Helps Surgeons Remove Tiny Ovarian Tumors Imaging System Helps Surgeons Remove Tiny Ovarian Tumors
    FDA Halts Sale of Pelvic Mesh in U.S. FDA Halts Sale of Pelvic Mesh in U.S.
    Pain in the (Supply) Chain: Tariffs and U.S.-China Medtech Trade Pain in the (Supply) Chain: Tariffs and U.S.-China Medtech Trade
    Nortech Systems Names President and CEO Nortech Systems Names President and CEO
    Medical Device Vigilance Market Will Exceed $91.5B by 2025 Medical Device Vigilance Market Will Exceed $91.5B by 2025
    Alliance for Artificial Intelligence in Healthcare Announces Inaugural Board of Directors, Officers Alliance for Artificial Intelligence in Healthcare Announces Inaugural Board of Directors, Officers
    Oxygen-Tracking Method Could Improve Diabetes Treatment Oxygen-Tracking Method Could Improve Diabetes Treatment
    New MRI Sensor Can Image Activity Deep within the Brain New MRI Sensor Can Image Activity Deep within the Brain

    Related Breaking News

    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19

    • Diagnostics
      NeuMoDx Molecular and Sentinel Diagnostics Partner

      NeuMoDx Molecular and Sentinel Diagnostics Partner

      Work together to develop multiple new assays for the NeuMoDx Molecular Systems.
      NeuMoDx Molecular 12.10.19

    • Diagnostics
      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant.
      Business Wire 12.09.19


    • Diagnostics
      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      Company is in the process of scaling up its capacity to move into full production in 2020.
      Business Wire 12.09.19

    • Diagnostics
      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      BD MAX Check-Points CPO assay can identify the five most common carbapenemase genes from patients.
      BD 12.09.19

    • Diagnostics
      FDA OKs Roche

      FDA OKs Roche's Nasal Swab MRSA Test

      The cobas vivoDx MRSA test can detect the bacteria in as little as five hours.
      U.S. Food and Drug Administration 12.06.19


    • Diagnostics | Digital Health | Software & IT
      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Aim is to help pathologists identify, quantify, and characterize cancer in tissue samples and make precise diagnoses more efficiently.
      Philips 12.05.19

    • Diagnostics | Neurological
      Eye Test for Parkinson

      Eye Test for Parkinson's Gains Breakthrough Designation

      The RightEye Vision System identifies ocular tremors that may help to detect the disease at an earlier stage.
      PR Newswire 12.05.19

    • Diagnostics | Neurological
      RSNA News: MaxQ AI Expands Partnership with GE

      RSNA News: MaxQ AI Expands Partnership with GE

      MaxQ AI’s ACCIPIO ICH and Stroke platform will be integrated into GE Healthcare’s PACS solution.
      MaxQ Al 12.04.19


    • Diagnostics | Neurological
      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      Represents cost savings and increased quality of care.
      MaxQ AI 12.04.19

    • Diagnostics
      Hyperfine Introduces World’s First Point-of-Care MRI System

      Hyperfine Introduces World’s First Point-of-Care MRI System

      The company's portable MRI is 20 times less costly, 35 times lower power, and 10 times lighter than the most popular current MRI machines.
      Business Wire 12.04.19

    • Diagnostics | Neurological
       RSNA News: MaxQ AI’s Software Integrated with Philips

      RSNA News: MaxQ AI’s Software Integrated with Philips' Tech

      The company’s Accipio Intracranial Hemorrhage and stroke software will be added to Philips’ CT systems
      MaxQ 12.04.19

    • Diagnostics
      RSNA News: Philips Transitions to the Circular Economy

      RSNA News: Philips Transitions to the Circular Economy

      Collecting and repurposing all the large medical systems equipment.
      Philips 12.03.19

    • Diagnostics
      RSIP Vision Introduces AI-Based Multiplex IF Image Analysis Solution

      RSIP Vision Introduces AI-Based Multiplex IF Image Analysis Solution

      Provides precise results in tissue diagnosis.
      PRNewswire 12.03.19

    • Diagnostics
      RSNA News: Philips Partners with Inspira Health

      RSNA News: Philips Partners with Inspira Health

      Aims to transform patient care for residents of southern New Jersey.
      Royal Philips 12.03.19


    Breaking News
    • Celmatix Sues Research Partner 23andMe for $100M
    • FDA Cleared New Cochlear Osia 2 System
    • FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    • Lens-Free Microendoscope Generates High Quality Images
    • Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Celmatix Sues Research Partner 23andMe for $100M
    FDA Cleared New Cochlear Osia 2 System
    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Omet India opens in New Delhi
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.